SpaceX Stock's Biggest Test Isn't Its Post-IPO Drop. It's Coming in Late July.

SpaceX is trading around $185 after pricing its IPO at $135 and briefly moving above $200, but the key catalyst is late July or early August when the first earnings report and staggered lockup release could add supply. The prospectus showed about $18.7 billion in 2025 revenue, $11.4 billion from Starlink, and a net loss of roughly $4.9 billion, with the AI segment contributing more than $6 billion in losses. The article argues the stock remains expensive at about $2.4 trillion and warns that the first real earnings update may test valuation and investor demand.

Analysis

The setup is less about the recent price chop and more about a classic post-IPO supply overhang colliding with a first fundamental print. When a thin float is repriced on narrative alone, the first real increase in lendable/sellable shares usually matters more than the headline earnings number because marginal buyers shift from momentum funds to valuation-aware capital. That creates a window where even decent results can disappoint if the market has already front-run perfection.

The key second-order issue is that the business mix is more fragile than the equity story implies. The high-margin recurring segment is doing the valuation heavy lifting, while the capital-intensive launch and AI ambitions can burn optionality quickly if management chooses to reinvest aggressively; that means any sign of slower subscription adds or faster cash burn could compress the multiple disproportionately. In other words, this is not just an earnings event — it is a credibility event on how much of the long-duration thesis can be monetized without continual dilution or leverage to fund it.

The consensus seems to be anchoring on the scarcity/AI/space optionality and underestimating how aggressively supply can clear when lockup windows open into a valuation stretched far beyond current earnings power. The more interesting contrarian trade is not to fade the business long term, but to fade the near-term reflexivity: once the first tranche of insiders can sell, strong tape can flip into distribution if early holders treat the IPO pop as liquidity. That creates a tradable skew where downside into the first report is more attractive than chasing upside before the market has to absorb both new shares and verified numbers.

Key Decisions for Investors

• Avoid initiating new longs ahead of the late-July/early-August earnings window; wait for the first print and lockup supply to clear, then reassess on post-event volume and guidance quality.
• If liquid options are available, buy 1-3 month put spreads into the event to express downside from supply-overhang + execution risk; target a 2:1 or better payoff if the stock mean-reverts toward the IPO area.
• Pair trade: long NVDA / short SPCX on a relative basis if you want AI exposure without paying for unproven, capital-intensive optionality; NVDA has monetization today, SPCX has multiple expansion embedded already.
• For investors already holding shares, trim 25-50% into any pre-earnings strength above the implied unlock threshold; risk/reward deteriorates sharply once insiders gain incremental monetization rights.
• Set a trigger to go tactical long only if the first report shows both accelerating recurring revenue and lower-than-feared cash burn; absent that combination, the stock remains a sell-the-rip candidate.